about
Advancements in stem cells treatment of skeletal muscle wastingClinical applications of mesenchymal stem cells in chronic diseases.Influence of immune responses in gene/stem cell therapies for muscular dystrophies.Exome sequencing identifies variants in two genes encoding the LIM-proteins NRAP and FHL1 in an Italian patient with BAG3 myofibrillar myopathy.Longitudinal MRI quantification of muscle degeneration in Duchenne muscular dystrophy.Expression of CD20 reveals a new store-operated calcium entry modulator in skeletal muscle.Novel insight into stem cell trafficking in dystrophic muscles.NEU3 sialidase strictly modulates GM3 levels in skeletal myoblasts C2C12 thus favoring their differentiation and protecting them from apoptosis.Inositol 1,4,5-trisphosphate (IP3)-dependent Ca2+ signaling mediates delayed myogenesis in Duchenne muscular dystrophy fetal muscle.Improvement of endurance of DMD animal model using natural polyphenols.Full-length dysferlin expression driven by engineered human dystrophic blood derived CD133+ stem cells.Therapeutic Potential of Immunoproteasome Inhibition in Duchenne Muscular Dystrophy.Adaptive Immune Response Impairs the Efficacy of Autologous Transplantation of Engineered Stem Cells in Dystrophic Dogs.Stem Cell-Mediated Exon Skipping of the Dystrophin Gene by the Bystander Effect.Absence of T and B lymphocytes modulates dystrophic features in dysferlin deficient animal model.Fibrosis Rescue Improves Cardiac Function in Dystrophin-Deficient Mice and Duchenne Patient-Specific Cardiomyocytes by Immunoproteasome ModulationCreatine kinase elevation: a neglected clue to the diagnosis of polymyositis. A case reportPCSK9 Expression in Epicardial Adipose Tissue: Molecular Association with Local Tissue Inflammation
P50
Q26822437-8031E1EE-B359-43CE-A64A-9E6CAD2A9040Q30437823-83D8FDC7-9C41-4F80-9717-89E4EBAFA310Q33736192-7EBAC22C-A52D-4BB3-9EB5-2A02646B01AFQ37231073-852C8F46-BE8D-41F1-9D5C-52FC8569BC9EQ38823382-38B593E1-E01C-4448-BBA3-B6E9549FE190Q39278027-8B152F55-AD39-439E-BB4A-4D011BD7DA43Q39587585-83222490-BE99-49E6-8554-77F9ABC971E4Q39926388-B952867C-3BFB-4134-8C7C-36E6BED0E294Q39991888-1CE16AA1-EE14-4BD1-BED0-6763F51A8ECFQ41091176-AF8802AC-7576-4113-8EE1-5BDF41A1C009Q42270238-142600E5-2152-4B6D-84F0-A8A765AFC433Q42859444-FDB4A9C3-366C-4E33-B593-A8443BAF3F90Q42859445-645C7A76-6180-4DC8-B097-A54FC6FB16FEQ45879562-3CFFE05F-0136-4AB7-A7EF-7C69BAF41BFDQ54520022-CCA0F241-6B96-4814-AA43-F4416DB4B3FEQ93193777-0BC78CCC-F71F-4CCE-891E-E14D5072C6BAQ93339318-6F0EC427-F679-4B86-90DC-7AC9ACD1EE82Q96605065-4CB8CE7A-A660-4677-A28E-BF776CE77405
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Clementina Sitzia
@ast
Clementina Sitzia
@en
Clementina Sitzia
@es
Clementina Sitzia
@nl
type
label
Clementina Sitzia
@ast
Clementina Sitzia
@en
Clementina Sitzia
@es
Clementina Sitzia
@nl
prefLabel
Clementina Sitzia
@ast
Clementina Sitzia
@en
Clementina Sitzia
@es
Clementina Sitzia
@nl
P106
P1153
55178949700
P31
P496
0000-0001-5415-7597